Caroline Dougherty
Vice President, Corporate Development @ Latigo Biotherapeutics, Inc.
About
Business Development and Corporate Strategy Professional having worked across five therapeutic areas and 17 transactions, totaling $750M of biotech capital (upfronts, equity, project financing) and $6B of M&A. Functional team leader (including P&L), experienced in strategic partnerships, M&A, portfolio prioritization, capital formation & allocation, valuation, alliance management, and new product planning.
United States
San Francisco Bay Area
Biotechnology
Economics, Financial Modeling, Data Analysis, Microsoft Excel, Research, Market Analysis, Stata, Microsoft Office, PowerPoint, Public Speaking
Experience

Senior Director, Business Development
Cerevel Therapeutics
Acquired by AbbVie for $8.7B. Joined as one of first 20 employees.
Caroline Dougherty's Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles

Find Emails
Access verified email addresses for your target contacts.
657M+ emails

Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers

More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.









